PoniardNeoRx Corporation is changing its name to Poniard Pharmaceuticals, Inc. effective 5 p.m. PT June 16, 2006

Investor Relations

The investor pages that follow are your resource for financial information about Poniard Pharmaceuticals. In this section you will find information about our current and historical share price, analyst coverage, SEC filings, an electronic version of our annual report and frequently asked questions as well as forms to request additional information.

Recent Releases

Jul 31, 2008
Poniard Pharmaceuticals Reports Second Quarter 2008 Financial Results and Corporate Update

Jul 31, 2008
Poniard Pharmaceuticals to Present at the 4th Annual Moores UCSD Cancer Center Translational Oncology Symposium

more »

Events

Aug 5, 2008
BMO Capital Markets' 2008 Focus on Healthcare Conference

Aug 4, 2008
Oppenheimer Small and Mid Cap Clinical and Regulatory Panel Discussion

more »


Stock Information
PARD - (NASD)
$4.14   + 0.09
Aug 21, 2008
3:26 PM ET

Quotes delayed at least 20 minutes. Information provided by TurboFeed.

About Poniard | Programs | Clinical Trials | Investors | News & Events | Contact